May 29, 2015 /

CAT-1004 (Catabasis) Clinical Trial Webinar (May 2015)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy


CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015]

On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy.
Research & Clinical Trial Webinars, Webinars
Posted on May 29, 2015
LinkedinPin ItWhatsApp

Join Our Mailing List